Literature DB >> 28094266

Cancer metabolism: a therapeutic perspective.

Ubaldo E Martinez-Outschoorn, Maria Peiris-Pagés, Richard G Pestell, Federica Sotgia, Michael P Lisanti.   

Abstract

Entities:  

Year:  2017        PMID： 28094266     DOI： 10.1038/nrclinonc.2017.1

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

Review 1.  Cancer metabolism: a therapeutic perspective.

Authors:  Ubaldo E Martinez-Outschoorn; Maria Peiris-Pagés; Richard G Pestell; Federica Sotgia; Michael P Lisanti
Journal:  Nat Rev Clin Oncol       Date:  2016-05-04       Impact factor: 66.675
  1 in total
  65 in total

1.  Engineering Multifunctional RNAi Nanomedicine To Concurrently Target Cancer Hallmarks for Combinatorial Therapy.

Authors:  Yanlan Liu; Xiaoyuan Ji; Winnie W L Tong; Diana Askhatova; Tingyuan Yang; Hongwei Cheng; Yuzhuo Wang; Jinjun Shi
Journal:  Angew Chem Int Ed Engl       Date:  2018-01-16       Impact factor: 15.336

2.  GLUT1 expression in high-risk prostate cancer: correlation with 18F-FDG-PET/CT and clinical outcome.

Authors:  Salma Meziou; Cassandra Ringuette Goulet; Hélène Hovington; Véronique Lefebvre; Étienne Lavallée; Michelle Bergeron; Hervé Brisson; Audrey Champagne; Bertrand Neveu; Didier Lacombe; Jean-Mathieu Beauregard; François-Alexandre Buteau; Julie Riopel; Frédéric Pouliot
Journal:  Prostate Cancer Prostatic Dis       Date:  2020-01-13       Impact factor: 5.554

Review 3.  How do cancer cells replenish their fuel supply?

Authors:  Abdallah K Alameddine; Frederick T Conlin; Brian J Binnall; Yvonne A Alameddine; Khaled O Alameddine
Journal:  Cancer Rep (Hoboken)       Date:  2018-04-30

4.  Near-simultaneous quantification of glucose uptake, mitochondrial membrane potential, and vascular parameters in murine flank tumors using quantitative diffuse reflectance and fluorescence spectroscopy.

Authors:  Caigang Zhu; Hannah L Martin; Brian T Crouch; Amy F Martinez; Martin Li; Gregory M Palmer; Mark W Dewhirst; Nimmi Ramanujam
Journal:  Biomed Opt Express       Date:  2018-06-27       Impact factor: 3.732

5.  Targeting tumor phenotypic plasticity and metabolic remodeling in adaptive cross-drug tolerance.

Authors:  Aaron Goldman; Sachin Khiste; Elizaveta Freinkman; Andrew Dhawan; Biswanath Majumder; Jayanta Mondal; Anthony B Pinkerton; Elliot Eton; Ragini Medhi; Vineethkrishna Chandrasekar; M Mamunur Rahman; Takaharu Ichimura; Kodaganur S Gopinath; Pradip Majumder; Mohammad Kohandel; Shiladitya Sengupta
Journal:  Sci Signal       Date:  2019-08-20       Impact factor: 8.192

6.  Targeting of Hematologic Malignancies with PTC299, A Novel Potent Inhibitor of Dihydroorotate Dehydrogenase with Favorable Pharmaceutical Properties.

Authors:  Liangxian Cao; Marla Weetall; Christopher Trotta; Katherine Cintron; Jiyuan Ma; Min Jung Kim; Bansri Furia; Charles Romfo; Jason D Graci; Wencheng Li; Joshua Du; Josephine Sheedy; Jean Hedrick; Nicole Risher; Shirley Yeh; Hongyan Qi; Tamil Arasu; Seongwoo Hwang; William Lennox; Ronald Kong; Janet Petruska; Young-Choon Moon; John Babiak; Thomas W Davis; Allan Jacobson; Neil G Almstead; Art Branstrom; Joseph M Colacino; Stuart W Peltz
Journal:  Mol Cancer Ther       Date:  2018-10-23       Impact factor: 6.261

Review 7.  The Metabolic Profiles in Hematological Malignancies.

Authors:  Tao Liu; Xing-Chun Peng; Bin Li
Journal:  Indian J Hematol Blood Transfus       Date:  2019-04-23       Impact factor: 0.900

8.  Reprograming of Glucose Metabolism by Zerumbone Suppresses Hepatocarcinogenesis.

Authors:  Nissar Ahmad Wani; Bo Zhang; Kun-Yu Teng; Juan M Barajas; Tasneem Motiwala; Peng Hu; Lianbo Yu; Rafael Brüschweiler; Kalpana Ghoshal; Samson T Jacob
Journal:  Mol Cancer Res       Date:  2017-11-29       Impact factor: 5.852

9.  Simultaneous in vivo optical quantification of key metabolic and vascular endpoints reveals tumor metabolic diversity in murine breast tumor models.

Authors:  Caigang Zhu; Martin Li; Thomas Vincent; Hannah L Martin; Brian T Crouch; Amy F Martinez; Megan C Madonna; Gregory M Palmer; Mark W Dewhirst; Nimmi Ramanujam
Journal:  J Biophotonics       Date:  2019-01-28       Impact factor: 3.207

10.  Dihydroartemisinin Inhibits the Proliferation of Leukemia Cells K562 by Suppressing PKM2 and GLUT1 Mediated Aerobic Glycolysis.

Authors:  Peng Gao; Shuo Shen; Xiaodong Li; Dandan Liu; Yuqing Meng; Yanqing Liu; Yongping Zhu; Junzhe Zhang; Piao Luo; Liwei Gu
Journal:  Drug Des Devel Ther       Date:  2020-05-27       Impact factor: 4.162
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.